Study identifier:D5252R00002
ClinicalTrials.gov identifier:NCT03556475
EudraCT identifier:N/A
CTIS identifier:N/A
A diagnostic test to develop an AECOPD identification tool through characteristic variables extracted from diagnosed AECOPD patients
Acute exacerbations of COPD
N/A
No
-
All
300
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Apr 2022 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Disease 1 Moderate to severe COPD Patients(n=90) | - |
Disease type 2-1) Patients with Mild/moderate AECOPD (n=60) | - |
Disease type 2-2) Patients with Severe AECOPD( n=60) | - |
Disease type 3 Non-COPD Patients with high risk factors (n=90) | - |